1. Home
  2. ARWR vs PAY Comparison

ARWR vs PAY Comparison

Compare ARWR & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • PAY
  • Stock Information
  • Founded
  • ARWR 2003
  • PAY 2004
  • Country
  • ARWR United States
  • PAY United States
  • Employees
  • ARWR N/A
  • PAY N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • PAY Computer Software: Prepackaged Software
  • Sector
  • ARWR Health Care
  • PAY Technology
  • Exchange
  • ARWR Nasdaq
  • PAY Nasdaq
  • Market Cap
  • ARWR 5.1B
  • PAY 4.4B
  • IPO Year
  • ARWR 1993
  • PAY 2021
  • Fundamental
  • Price
  • ARWR $39.24
  • PAY $30.28
  • Analyst Decision
  • ARWR Strong Buy
  • PAY Buy
  • Analyst Count
  • ARWR 8
  • PAY 7
  • Target Price
  • ARWR $47.75
  • PAY $36.50
  • AVG Volume (30 Days)
  • ARWR 1.8M
  • PAY 722.5K
  • Earning Date
  • ARWR 11-25-2025
  • PAY 11-03-2025
  • Dividend Yield
  • ARWR N/A
  • PAY N/A
  • EPS Growth
  • ARWR N/A
  • PAY 69.57
  • EPS
  • ARWR N/A
  • PAY 0.44
  • Revenue
  • ARWR $572,976,000.00
  • PAY $1,044,760,000.00
  • Revenue This Year
  • ARWR $21,287.22
  • PAY $30.89
  • Revenue Next Year
  • ARWR N/A
  • PAY $20.25
  • P/E Ratio
  • ARWR N/A
  • PAY $69.73
  • Revenue Growth
  • ARWR 2816.20
  • PAY 49.35
  • 52 Week Low
  • ARWR $9.57
  • PAY $22.65
  • 52 Week High
  • ARWR $40.48
  • PAY $40.43
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 65.60
  • PAY 43.74
  • Support Level
  • ARWR $36.73
  • PAY $29.23
  • Resistance Level
  • ARWR $40.48
  • PAY $31.78
  • Average True Range (ATR)
  • ARWR 1.70
  • PAY 1.04
  • MACD
  • ARWR -0.20
  • PAY 0.23
  • Stochastic Oscillator
  • ARWR 78.79
  • PAY 55.73

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

Share on Social Networks: